Exeltis Pharmaceuticals Holding, S.L.
Exeltis Pharmaceuticals Holding, S.L., commonly referred to as Exeltis, is a prominent player in the global pharmaceutical industry, headquartered in Spain. Founded in 2015, the company has rapidly expanded its operations across Europe, Latin America, and other key regions, focusing on innovative healthcare solutions. Specialising in women's health, dermatology, and other therapeutic areas, Exeltis is recognised for its commitment to developing unique products that address unmet medical needs. The company’s portfolio includes a range of prescription medications and over-the-counter products, distinguished by their efficacy and safety profiles. With a strong market presence, Exeltis has achieved significant milestones, including strategic partnerships and a growing international footprint, positioning itself as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Exeltis Pharmaceuticals Holding, S.L.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Exeltis Pharmaceuticals Holding, S.L.'s score of 18 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Exeltis Pharmaceuticals Holding, S.L.'s reported carbon emissions
Exeltis Pharmaceuticals Holding, S.L., headquartered in Spain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Exeltis may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the pharmaceutical industry, many companies are increasingly adopting science-based targets and sustainability practices to mitigate their environmental impact. However, without specific emissions data or commitments, it is unclear how Exeltis aligns with these industry trends. As the company moves forward, establishing measurable climate goals and reporting emissions could enhance its sustainability profile and contribute to broader environmental efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Exeltis Pharmaceuticals Holding, S.L. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
